AI assistant
AtriCure, Inc. — Director's Dealing 2021
May 24, 2021
31802_dirs_2021-05-24_689012af-4289-4ae7-b2f1-2d487eef7869.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2021-05-20
Reporting Person: Austin Tonya (Chief Human Resources Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 37712 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified Stock Option (right to buy) | $9.25 | 2023-05-13 | Common Stock (50000) | Direct | |
| Non-qualified Stock Option (right to buy) | $21.04 | 2024-01-24 | Common Stock (10000) | Direct |
Footnotes
F1: Includes 9,948 shares of unvested restricted stock awarded under the AtriCure, Inc. 2014 Equity Incentive Plan. One third of the shares vest annually upon the respective one, two and three year anniversaries of the date of grant. Includes 1,663 shares acquired under the AtriCure, Inc. Employee Stock Purchase Plan.
F2: These options were granted on May 13, 2013 and vest at a rate of 25% on the first anniversary date of the grant and ratably each month thereafter over the following three years.
F3: These options were granted on January 24, 2014 and vest at a rate of 25% on the first anniversary date of the grant and ratably each month thereafter over the following three years.